Clinical trial / 2016
Vaccinium uliginosum extract (1000 mg/day for 4 weeks) alleviated tablet computer-induced asthenopia symptoms.
A total of 60 volunteers were randomized to receive either 1000 mg/day of Vaccinium uliginosum extract (DA9301) or a placebo for 4 weeks to examine effects on tablet computer-induced asthenopia. At baseline, the total asthenopia score (TAS) increased significantly after tablet watching in the DA9301 group (from 20.35 to 23.88; p = 0.031), but remained stable after tablet watching following 4 weeks of supplementation. In the control group, TAS changes induced by tablet watching were not significant at either baseline or 4 weeks. Individual symptom scores for tired eyes, sore/aching eyes, irritated eyes, watery eyes, dry eyes, eye strain, blurred vision, and visual discomfort significantly improved in the DA9301 group.
- Study type
- Randomized, placebo-controlled, double-blind parallel study
- Who was studied
- 60 volunteers
- What was measured
- Change in total asthenopia score (TAS) and individual ocular symptoms
THE PAPER
The effect of Vaccinium uliginosum extract on tablet computer-induced asthenopia: randomized placebo-controlled study.
Park CY, Gu N, Lim CY, Oh JH, Chang M, Kim M, Rhee MY. BMC Complement Altern Med, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.